Literature DB >> 21307653

The clinical use of adjuvants in pneumococcal vaccination: current status and future perspectives.

Ole Schmeltz Søgaard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21307653     DOI： 10.4161/hv.7.2.13919

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN： 1554-8600


× No keyword cloud information.
  4 in total

Review 1.  High-affinity anti-glycan antibodies: challenges and strategies.

Authors:  Zinaida Polonskaya; Paul B Savage; M G Finn; Luc Teyton
Journal:  Curr Opin Immunol       Date:  2019-04-28       Impact factor: 7.486

2.  An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.

Authors:  James P Phipps; Karen M Haas
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

3.  TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity.

Authors:  Alicja Puchta; Avee Naidoo; Chris P Verschoor; Dessi Loukov; Netusha Thevaranjan; Talveer S Mandur; Phuong-Son Nguyen; Manel Jordana; Mark Loeb; Zhou Xing; Lester Kobzik; Maggie J Larché; Dawn M E Bowdish
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823

Review 4.  Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.

Authors:  Giuseppe Stefanetti; Francesco Borriello; Barbara Richichi; Ivan Zanoni; Luigi Lay
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.